K-ZPTO Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections of the skin. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. K-ZPTO Cream is indicated for the management of dermatophytosis, candidiasis, pityriasis versicolor, and seborrheic dermatitis. The formulation is intended for topical application and should be applied to the affected area once or twice daily as directed by a healthcare professional. Clinical efficacy is typically observed within 2 to 4 weeks of consistent use, although duration may vary depending on the severity and type of infection. K-ZPTO Cream is generally well tolerated; however, mild local adverse effects such as burning, itching, or irritation may occur. It is contraindicated in patients with known hypersensitivity to ketoconazole or any component of the formulation. Use with caution in pregnant or breastfeeding women, and avoid contact with eyes and mucous membranes. Patients should adhere to the prescribed treatment regimen and maintain proper hygiene to prevent recurrence. Consultation with a healthcare provider is recommended prior to initiating therapy to ensure appropriate diagnosis and use.